FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research
Domestic isotope supply issues, including implementation of the American Medical Isotopes Production Act of 2011
Implementation of Affordable Care Act (entire bill)
H.R. 1146 and S. 642 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2013), all provisions
Nuclear medicine reimbursement under the Physician Fee Schedule
Pharmacy compounding of medications
S. 959 (Pharmaceutical Quality, Security, and Accountability Act), entire bill
Duration: November 1, 2010
to
August 1, 2013
General Issues: Budget/Appropriations , Energy/Nuclear , Health Issues , Medicare/Medicaid , Pharmacy
Spending: about $260,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2010: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
3rd Quarter, 2013
Arent Fox LLP terminated an engagement in which they represented Society of Nuclear Medicine and Molecular Imaging on Oct. 18, 2013.
Original Filing: 300600685.xml
Lobbying Issues
FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research
Lobbying Issues
Domestic isotope supply issues, including implementation of the American Medical Isotopes Production Act of 2011
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 1146 and S. 642 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2013), all provisions
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Lobbying Issues
Pharmacy compounding of medications
S. 959 (Pharmaceutical Quality, Security, and Accountability Act), entire bill
2nd Quarter, 2013
In Q2, Arent Fox LLP lobbied for Society of Nuclear Medicine and Molecular Imaging , earning $30,000. The report was filed on July 18, 2013.
Original Filing: 300576864.xml
Lobbying Issues
FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including implementation of the American Medical Isotopes Production Act of 2011
Medical radiation issues, including Nuclear Regulatory Commission regulations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 1146 and S. 642 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2013), all provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Lobbying Issues
Pharmacy compounding of medications
S. 959 (Pharmaceutical Quality, Security, and Accountability Act), entire bill
1st Quarter, 2013
In Q1, Arent Fox LLP lobbied for Society of Nuclear Medicine and Molecular Imaging , earning $20,000. The report was filed on April 19, 2013.
Original Filing: 300557297.xml
Lobbying Issues
FY '13 (H.R. 5325/S. 2465; and H.R. 933 (Consolidated and Further Continuing Appropriations Act, 2013), Division F, Title II) regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research
FY '14 Energy/Water appropriations regarding Department of Energy funding opportunities for nuclear medicine research
S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy (all provisions)FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 1146 and S. 642 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2013), all provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
H.R. 8 (American Taxpayer Relief Act of 2012) regarding nuclear medicine reimbursement under the Physician Fee Schedule (Title VI)
4th Quarter, 2012
In Q4, Arent Fox LLP lobbied for Society of Nuclear Medicine and Molecular Imaging , earning $20,000. The report was filed on Jan. 17, 2013.
Original Filing: 300532001.xml
Lobbying Issues
FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 and S. 3338 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
3rd Quarter, 2012
In Q3, Arent Fox LLP lobbied for Society of Nuclear Medicine and Molecular Imaging (f/k/a Society of Nuclear Med) , earning $20,000. The report was filed on Oct. 17, 2012.
Original Filing: 300509472.xml
Lobbying Issues
FY '12 Department of Energy funding opportunities regarding nuclear medicine research
FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 and S. 3338 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
2nd Quarter, 2012
In Q2, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $20,000. The report was filed on July 15, 2012.
Original Filing: 300484322.xml
Lobbying Issues
FY '12 Department of Energy funding opportunities regarding nuclear medicine research
FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 and S. 3338 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Comparative Effectiveness Research (CER)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $20,000. The report was filed on April 17, 2012.
Original Filing: 300462634.xml
Lobbying Issues
FY '12 and FY '13 Department of Energy funding opportunities regarding nuclear medicine research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Comparative Effectiveness Research (CER)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $20,000. The report was filed on Jan. 18, 2012.
Original Filing: 300441129.xml
Lobbying Issues
FY '12 (H.R. 2354 and Senate bill (Title III), and Consolidated Appropriations Act, 2012) regarding Department of Energy funding opportunities for nuclear medicine research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Comparative Effectiveness Research (CER)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $20,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415572.xml
Lobbying Issues
FY '11 and FY '12 (H.R. 2354, and Senate bill) Department of Energy funding opportunities regarding nuclear medicine research (Title III)
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Comparative Effectiveness Research (CER)Department of Health and Human Services regulatory reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $30,000. The report was filed on July 15, 2011.
Original Filing: 300390717.xml
Lobbying Issues
FY '11 and FY '12 (H.R. 2354) Department of Energy funding opportunities regarding nuclear medicine research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
H.R. 2104 (Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011), all provisions
Comparative Effectiveness Research (CER)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $30,000. The report was filed on April 14, 2011.
Original Filing: 300364390.xml
Lobbying Issues
FY '11 and FY '12 Department of Energy funding opportunities regarding nuclear medicine research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011) (entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
Consistency, Accuracy, Responsibility and Excellence (CARE) in Medical Imaging and Radiation Therapy Act of 2011 (no bill)
Comparative Effectiveness Research (CER)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule
4th Quarter, 2010
In Q4, Arent Fox LLP lobbied for Society of Nuclear Medicine , earning $20,000. The report was filed on Jan. 19, 2011.
Original Filing: 300343827.xml
Lobbying Issues
FY '11 (S. 3635) Energy and Water Appropriations regarding Department Energy funding for nuclear medicine research (Title III), and Omnibus appropriations
FY '12 Department of Energy funding for nuclear medicine research
Lobbying Issues
Domestic isotope supply issues, including H.R. 3276 (American Medical Isotopes Production Act of 2010)(entire bill)
Medical radiation issues, including Nuclear Regulatory Commission regulations
Lobbying Issues
Implementation of Affordable Care Act (entire bill)
Lobbying Issues
Nuclear medicine reimbursement under the Physician Fee Schedule, including H.R. 4994 (Medicare and Medicaid Extenders Act of 2010) / H.R. 5712 (The Physician Payment and Therapy Relief Act of 2010) / H.R. 6459 (to amend section 1848 of the Social Security Act)(all provisions)
4th Quarter, 2010
Arent Fox LLP filed a lobbying registration on Nov. 28, 2010 to represent Society of Nuclear Medicine, effective Nov. 1, 2010.
Original Filing: 300333073.xml
Issue(s) they said they’d lobby about: FY '11 (S. 3635, Title III) Energy and Water Appropriations on DOE funding for nuclear medicine research; Domestic isotope supply issues, including H.R. 3276 (American Medical Isotopes Production Act of 2010)(entire bill); Medical radiation issues, including NRC regulations; Nuclear medicine reimbursement under the Physician Fee Schedule; Implementation of Affordable Care Act, entire bill; H.R. 3652 and S. 3737 (CARE in Medical Imaging and Radiation Therapy Act of 2009), entire bill .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...